A Study of Chidamide With AZA in MRD Positive AML After Transplant

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 26, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
AML, AdultMinimal Residual Disease
Interventions
DRUG

chidamide and azacitidine

"chidamide:10mg orally,day 1 to day 6 every week, Take it for two weeks, rest for two weeks,so 28 days for a circle, 12 circles totally.~azacitidine:50mg,subcutaneous injection,day 1 to day 5 every week, 28 days for a circle, 6 circles totally."

Trial Locations (1)

Unknown

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

All Listed Sponsors
collaborator

Shenzhen Chipscreen Biosciences Co.Ltd

UNKNOWN

lead

Guangdong Provincial People's Hospital

OTHER